In the early stages of drug development, IC50 values are used to select lead compounds from a library of candidates. Compounds with low IC50 values are considered more promising and are subjected to further testing, including in vivo studies and clinical trials. IC50 data also contribute to structure-activity relationship (SAR) studies, helping researchers understand how changes in chemical structure affect biological activity.
